Open original FDA record ↗Recall record
- FDA identifier
- Z-1107-2014
- Company in FDA record
- Philips Medical Systems, Inc.
- FDA classification date
- Feb 26, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
HeartStart XL+ battery charge time to 100% capacity at 35C (95F) is slightly longer than the specified 3 hour duration as stated in the labeling
Source facts
- Action
- Philips Healthcare issued a Customer Information Letter on January 24, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customers with an IFU Addendum titled: HeartStart XL+ Instructions for Use Addendum. Philips has revised the labeling in the addendum to specify the battery charge time with device turned off and AC power connected. The revised specification is: With temperature at 25C (77F), less than 3 hours to 100% capacity; less than 2 hours to 80% capacity. Please contact your local Philips Representative at 1-800-722-9377.
- Initiated
- 2014-01-24
- Root cause
- Component design/selection
- Terminated
- 2020-09-03
- Distribution
- Worldwide Distribution - USA (nationwide) including Puerto Rico and the countries of ALGERIA ANGOLA ARGENTINA AUSTRALIA AUSTRIA AZERBAIJAN BAHRAIN BELGIUM BOLIVIA BULGARIA CANADA CHILE CHINA COLOMBIA COSTA RICA CROATIA (local name: Hrvatska) CYPRUS CZECH REPUBLIC DENMARK DOMINICAN REPUBLIC EGYPT EL SALVADOR ESTONIA ETHIOPIA FINLAND FRANCE GABON GERMANY GREECE GUATEMALA HONG KONG HUNGARY ICELAND INDIA INDONESIA IRAN (ISLAMIC REPUBLIC OF) IRAQ IRELAND ISRAEL ITALY JORDAN KENYA KOREA, REPUBLIC OF KUWAIT LATVIA LEBANON LIBERIA LIBYAN ARAB JAMAHIRIYA LITHUANIA MACAU MALAYSIA MALTA MAURITIUS MOROCCO MYANMAR (Burma) NAMIBIA NETHERLANDS NEW ZEALAND NORWAY OMAN PALESTINE PERU PHILIPPINES POLAND PORTUGAL,QATAR ROMANIA RUSSIAN FEDERATION SAUDI ARABIA SENEGAL SERBIA SEYCHELLES SINGAPORE SLOVAKIA (Slovak Republic) SLOVENIA SOUTH AFRICA SPAIN SRI LANKA SWEDEN SWITZERLAND SYRIAN ARAB REPUBLIC TAIWAN, PROVINCE OF CHINA TANZANIA, UNITED REPUBLIC OF THAILAND TRINIDAD AND TOBAGO TUNISIA TURKEY UNITED ARAB EMIRATES UNITED KINGDOM and VIET NAM.
- Recall number
- Z-1107-2014
- Recall status
- Terminated
- CDRH record ID
- 125269
- FDA classified
- 2014-02-26
- Recall event number
- 67328